FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Interestingly, she is also rumored to be added to the permanent banner following her release. Furthermore, it is speculated that Travelers might also get a long-awaited rerun banner of the ...

HoYoverse has officially announced the complete banners and events schedule for Phase II of the ongoing Genshin Impact 5.3 update. The second half will feature the popular Lantern Rite event ...

Achieving global regulatory harmonization for biosimilar vaccines and immunotherapies is essential to improving market access, reducing costs, and enhancing patient outcomes by streamlining approval ...

Systemic lupus erythematosus (SLE) activity assessment often hinges on accurately identifying arthritis, a common manifestation, according to study ...

As for Aglaea, she is the first limited Remembrance character in the game, and will be a 5-star Lightning unit. In the story, she has the divine authority of “Romance” and is one of the ...

chief medical officer of Banner Research, director of the Banner Sun Health Research Institute, based in Arizona, and lecturer on neurology at Brigham and Women’s Hospital and Harvard Medical ...

Eight characters to choose from on Honkai Star Rail 3.0, which is the fairest of them all? Honkai Star Rail version 3.0 will have a whopping 8 character banners running across its six-week duration.